DONNA HODGES: Open Payments
NPI 1932272200 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,138 in 58 payments from 17 companies in 2025. Trend: 2023 $4,868 · 2024 $630 · 2025 $1,138
Food & beverage: $1,138
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 6 | $166 |
| Amgen Inc. | 10 | $164 |
| Lilly USA, LLC | 11 | $145 |
| Radius Health, Inc. | 5 | $138 |
| Novo Nordisk Inc | 6 | $110 |
| Sequel Med Tech, LLC | 3 | $56 |
| Corcept Therapeutics | 3 | $55 |
| Alexion Pharmaceuticals, Inc. | 2 | $49 |
| Tandem Diabetes Care, Inc. | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
Products named: Omnipod, MOUNJARO, EVENITY, Ozempic, TWIIST, Korlym, STRENSIQ, Rybelsus.
Industry payments across MS — which companies pay providers there.
